ARCoS is a pilot study evaluating the feasibility and preliminary effects of a method of cognitive remediation by a Rhythmic, Vocal and Embodied Musical Learning for a population of stabilized schizophrenic patients. 20 stabilized schizophrenics patients will participate in the study for 9 months, i) 6 months of Musical learning (24 sessions over the 6 months) ; ii) and 3 months of follow-up post cognitive remediation. Assessments of attention deficits, inhibitory abilities, negative symptoms and anxiety, will carried out at baseline (V1, M0), third month (M3), sixth month (M6) after the start of the intervention and third months after the end of the intervention (M9). The primary endpoint will be the proportion of patients who have attended at least 80% of the musical training sessions over the 6 months (participation in at least 19/24 sessions).
Schizophrenia is a chronic psychiatric condition affecting 1% of the population. Antipsychotic medications are effective on positive symptoms (delusions, hallucinations). However, they do not have a significant effect on negative symptoms (apragmatism, social withdrawal, blunting of affect, etc.) and cognitive impairment. These last two dimensions are the most impacting in terms of social functioning and quality of life, and antipsychotics can potentially aggravate them. In addition to pharmacological treatments it is recommended to combine non-pharmacological approaches including cognitive remediation and psychosocial rehabilitation. The latter are best able to improve the personal and interpersonal functioning of patients and improve their quality of life which makes a recovery trajectory possible. Do date very few studies conduct cognitive remediation using musical learning. We have created an original teaching method based on the embodied dimension of cognition. The objective is to conduct a first pilot study to validate the feasibility of this music learning with schizophrenic patients. It will allow a preliminary evaluation of the effects of this new approach on cognitive disorders and negative symptoms of stabilized schizophrenic patients. 20 stabilized schizophrenics patients will participate in the study for 9 months, i) Rhythmic, Vocal and Embodied Musical Learning to two groups of 10 patients during 6 months each. (24 sessions over the 6 months) ; ii) and 3 months of follow-up post cognitive remediation. Each patient will have 4 evaluation visits during the study.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
20
The musical learning method "Diapason \& Metronome" is unprecedented. It was specially created by Florent Cholat. It aims an apprenticeship of a musical practice adapted to subjects with schizophrenia. The method does not require the handling of a musical instrument; it is based on the voice and the body. It is built on the three essential dimensions of music, which are rhythm, single sound and harmony. "Rhythm" concerns the division and management of time. The "single sound" allows work on the representation of a sound object as a singularity. "Harmony" allows you to work on the positioning of a sound in the globality of the chord to which it belongs and in the collective polyphony exercises.
CH Marchant
Toulouse, France
CHU Toulouse
Toulouse, France
proportion of patients who have attended at least 80% of the musical training sessions over the 6 months
The primary outcomes will be the proportion of patients who have attended at least 80% of the musical training sessions over the 6 months (participation in at least 19/24 sessions).
Time frame: 6 months
list of factors of no adherence to musical learning
Describe the causes of no adherence to the project and the difficulties encountered during the study.
Time frame: 6 months
Reduce of attention deficits at 6 month
change of score of attention deficit (d2-R : Revised Focused Attention Test) between inclusion and the end of the program (M6)
Time frame: 6 months
Reduce of attention deficits at 9 month
change of score of attention deficit (d2-R : Revised Focused Attention Test) between inclusion and 3 months after (M9)
Time frame: 9 months
Improving inhibitory abilities at 6 month
change of score of attention deficit (Go-no-Go) between inclusion and the end of the program (M6)
Time frame: 6 months
Improving inhibitory abilities at 9 month
change of score of attention deficit (Go-no-Go) between inclusion and 3 months after (M9)
Time frame: 9 months
Decrease on Negative symptoms
change of score the Self evaluation of negative symptoms (SNS) between inclusion and the end of the program (M6), and between inclusion and 3 months after (M9)
Time frame: 6 months
The state of anxiety at 6 month
change of scores of State-Trait Anxiety Inventory (STAI) between inclusion and the end of the program (M6)
Time frame: 6 months
The state of anxiety at 9 month
change of scores of State-Trait Anxiety Inventory (STAI) between inclusion and 3 months after (M9)
Time frame: 6 months
modification of psychotropic medication
The modification of psychotropic medication at the end of the program compared to inclusion
Time frame: 6 months
modification of psychotropic medication
The modification of psychotropic medication at 3 months after (post cognitive remediation phase) compared to inclusion
Time frame: 9 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.